A critical breakthrough in cancer research is arising with the use of mini-antibodies to re-engage dysfunctional p53. This vital malignant protector protein is frequently inactivated in several types of tumors, causing https://thekiwisocial.com/story7566922/nanobodies-revive-the-p53-protein-the-new-pathway-for-cancer-management